Pelthos Therapeutics
PTHS · NYSE American
$20.50+$0.24 (+1.18%)TodayMarket closed ·
Prev close $20.26
About PTHS
- Employees
- 92
- Headquarters
- Durham, North Carolina
- Listed
- Feb 16, 2024
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- ir.pelthos.com
Leadership
| Name | Title | Since |
|---|---|---|
| Peter Greenleaf | — | — |
| Scott Plesha | — | 2025 |
| Francis Knuettel | — | — |
| Sai Rangarao | — | — |
| Andrew Einhorn | — | — |
| Richard Baxter | — | — |
| Todd Davis | — | — |
| Ezra Friedberg | — | — |
| Richard Malamut | — | — |
| Matthew Pauls | — | — |
Similar companies
Companies in the same industry as Pelthos Therapeutics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.